Table 3.
1-Fold Cmax | 20-Fold Cmax a | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Test | Data | Procedure | AUC | Accuracy | Sensitivity | Specificity | AUC | Accuracy | Sensitivity | Specificity |
UKN1 | Cytotoxicity | 0.63 | 0.56 | 0.26 | 1 | 0.73 | 0.67 | 0.46 | 1 | |
Gene expression | SPS | 0.78 | 0.64 | 0.43 | 0.94 | 0.82 | 0.62 | 0.38 | 1 | |
Top-1000 | 0.84 | 0.69 | 0.70 | 0.69 | 0.90 | 0.59 | 0.46 | 0.8 | ||
Cytotoxicity and gene expression | SPS | 0.84 | 0.79 | 0.70 | 0.94 | 0.90 | 0.90 | 0.83 | 1 | |
Top-1000 | 0.88 | 0.85 | 0.96 | 0.69 | 0.95 | 0.87 | 0.92 | 0.8 | ||
RT-qPCR (SPS-like) |
Not calculated | 0.74 | 0.57 | 1 | Not calculated | 0.90 | 0.83 | 1 | ||
RT-qPCR (Top-1000-like) |
0.76 | 0.77 | 0.74 | 0.81 | 0.91 | 0.87 | 0.88 | 0.87 | ||
UKK2 | Cytotoxicity | 0.61 | 0.54 | 0.22 | 1 | 0.63 | 0.54 | 0.25 | 1 | |
Gene expression | SPS | 0.87 | 0.77 | 0.61 | 1 | 0.83 | 0.69 | 0.58 | 0.87 | |
Top-1000 | 0.93 | 0.79 | 0.74 | 0.88 | 0.92 | 0.77 | 0.71 | 0.87 | ||
Cytotoxicity and gene expression | SPS | 0.9 | 0.9 | 0.83 | 1 | 0.87 | 0.85 | 0.83 | 0.87 | |
Top-1000 | 0.95 | 0.92 | 0.96 | 0.88 | 0.94 | 0.92 | 0.96 | 0.87 | ||
Combination ‘mean’ | Cytotoxicity | 0.63 | 0.56 | 0.26 | 1 | 0.73 | 0.67 | 0.46 | 1 | |
Gene expression | SPS | 0.89 | 0.77 | 0.61 | 1 | 0.84 | 0.64 | 0.42 | 1 | |
Top-1000 | 0.94 | 0.79 | 0.74 | 0.88 | 0.96 | 0.79 | 0.75 | 0.87 | ||
Cytotoxicity and gene expression | SPS | 0.92 | 0.92 | 0.87 | 1 | 0.91 | 0.92 | 0.88 | 1 | |
Top-1000 | 0.95 | 0.92 | 0.96 | 0.88 | 0.98 | 0.95 | 1 | 0.87 |
Cytotoxicity = Only cytotoxicity data were considered for the calculation of the metrics, i.e., cytotoxic conditions were considered as positive and non-cytotoxic conditions as negative test results. Gene expression = only gene expression data were considered for the calculation of the metrics. Cytotoxicity and gene expression = all data for cytotoxicity, as well as for gene expression, were considered for the calculation of the metrics. AUC (area-under-curve) = for each possible cut-off used as threshold, predictions were made for each of the conditions based on which sensitivity and specificity were calculated. The ROC-curve (receiver operator characteristic) was obtained by plotting all pairs of (1-specificity) and sensitivity against each other. The AUC was determined as the area under this ROC-curve. Accuracy = ratio of correct predictions ((true negatives and positives)/(true and false negatives and positives)) (Supplementary Table S1). Sensitivity = ratio of detected teratogens (true positives/(false negatives + true positives)) (Supplementary Table S1). Specificity = ratio of detected non-teratogens (true negatives/(true negatives + false positives)) (Supplementary Table S1. a Including 10-fold Cmax carbamazepine, 1.67-fold Cmax VPA, and 1-fold Cmax samples of leflunomide, phenytoin, teriflunomide, and vismodegib. RT-qPCR metrics used 1-fold Cmax results instead of 20-fold Cmax results for levothyroxine. Bold = best metrices for each test for the SPS- and top-1000-procedure and RT-qPCR.